SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-029750
Filing Date
2020-05-15
Accepted
2020-05-15 16:48:50
Documents
2
Period of Report
2020-05-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1655
2 POA DOCUMENT poa.txt EX-24.3_915322 3998
  Complete submission text file 0001209191-20-029750.txt   7131
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Issuer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140
Business Address
Alfieri Michael (Reporting) CIK: 0001744687 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37695 | Film No.: 20886265